R&D
Reuters Pharma USA 2024 – Lung-I Cheng
Cell and gene therapies were a major topic of discussion this year at Reuters Pharma USA in Philadelphia.
R&D
Reuters Pharma USA 2024 – Jeffrey Meckler
Most of the exciting work being done right now in cancer immunotherapy is centred on highly targeted approaches that aim to activate only the most necessary immune responses to eliminate a
R&D
Reuters Pharma USA 2024 – Blair McNeill
In today's era of cell, gene, and tissue therapies, new treatments are truly game-changing, often creating an opportunity for a healthy, normal life for people who previously had no options
Digital
Reuters Pharma USA 2024 – Mindy McGrath
One of the most salient topics in the United States right now in pharma is market access and drug affordability, and one thing that’s driving that topic in this moment are the drug pricing
R&D
Health Innovators – Pierre Luzeau
Getting a drug from idea to market is a complex process that requires a number of stakeholders, from research to development to manufacturing.
Editor's Picks
Editor's Picks
